Pradaxa Lawsuit: Lawyers Representing Minnesota Woman Who Almost Died from Internal Bleeding
Attorney Fred Pritzker 
Pradaxa, a blood thinner, can cause internal bleeding. Contact our law firm for a free case review: 1-888-377-8900.
Attorneys Brendan Flaherty, David Szerlag and I are representing a Pradaxa bleeding victim in Minnesota. Our client, an elderly woman, suffered extensive internal bleeding after taking Pradaxa (dabigatran etexilate), a blood thinner approved by the FDA in 2010. She was then hospitalized for 8 days and nearly died.
Contact our attorneys about a Pradaxa lawsuit against Boehringer Ingleheim Phramaceuticals, the manufacturer of Pradaxa. Talking with to an attorney at our law firm about your personal injury or wrongful death Pradaxa claim is free. If you hire our law firm to represent you, you do not have to pay any fee unless we win your case. Call Brendan at 1-888-377-8900 or submit our free consultation form.
Since its approval by the FDA, there have been over 500 reports of serious injury and death in the United States caused by Pradaxa. Over 260 people worldwide have died from internal bleeding after taking Pradaxa. The problem is that there is no antidote that can be given to Pradaxa patients to stop severe bleeding, unlike with other blood thinners, where vitamin K will stop excessive bleeding (hemorrhaging). Although the FDA has issued a warning, there has not been a Pradaxa recall.
Any of the following can cause serious, permanent injury or death:
- Gastrointestinal (GI) bleeding (bleeding anywhere in the GI track, including the esophagus, stomach, small intestine, large intestine or colon, rectum or anus)
- Bleeding on the brain, which causes hemorrhagic stroke
- Cardiovascular hemorrhage (bleeding of the heart that causes a heart attack)
- Pulmonary hemorrhage (bleeding of the lung that can cause liver failure).
If you have any of the following symptoms and you are taking Pradaxa, you need to get medical attention as soon as possible:
- Unusual bleeding, particularly from the nose, which has been the first sign of Pradaxa internal bleeding for many patients
- Unusual bruising
- Coughing up or vomiting blood
- Blood passed from the rectum
- Headaches and dizziness
- Weakness or swelling of arms and legs
- Pink or brown colored urine
- Red (bloody) or black tarry stools.
Attorneys Brendan Flaherty, David Szerlag and I were on the litigation team that won over $20,000,000 for our clients who were injured by another medical product, an over-the-counter product that caused kidney failure. That product was eventually recalled. Our law firm represents clients nationwide in personal injury and wrongful death lawsuits involving dangerous and defective drugs and other medical products. Our offices are in Minneapolis, Minnesota.
Fake Avastin Given to Cancer Patients: Free Consultation with Attorney
Fred Pritzker
Fake Avastin was sold in the U.S.
At least 20 medical practices may have given patients fake Avastin, an injectable medicine used to treat cancer and is administered to patients in clinics, hospitals, and doctors’ offices. The counterfeit version of Avastin does not contain the medicine’s active ingredient, bevacizumab, which may have resulted in patients not receiving needed therapy.
These medical practices purchased the Avastin from foreign sources that are unapproved by the FDA, and they are liable for the damage caused to patients by the decision to purchase the fake Avastin. Because the purchase was a violation of federal regulations, patients given the fake Avastin may have claims for punitive damages against the doctors and others. With punitive damages, the money rewarded is meant to be in an amount that is high enough to punish the responsible parties.
Contact me for a free consultation regarding a lawsuit against one of the medical practices listed below:
- Beverly Hills Cancer Center
- Dennis Casciato, MD
- Phillip L. Chatham, MD
- Weber Chen, MD
- Mohamed Ghraowi, MD
- Mark Goldstein, MD
- Naresh K. Gupta, MD
- Raymond Heung, MD
- Eddie Hu, MD
- Hany Khalil, MD
- Phyllis Klein, MD
- McLeod Cancer and Blood Center
- Harry Menco, MD
- R. Deva Nathan, MD
- Martin Palmer, MD
- Nabil Phillips, MD
- Omid S. Shaye, MD
- Patrick Sheehy, MD
- Glenn Tisman, MD
- Rangachari Vasan, MD
The fake version is labeled as Avastin, manufactured by Roche. Roche is the company that manufactures Avastin approved for marketing outside of the United States. The only FDA-approved version of Avastin for use in the United States is marketed by Genentech (a member company of Roche). The FDA-approved version does not include the Roche logo on the packaging or vials.
The 20 medical practices in the United States purchased unapproved cancer medicines and, potentially, the fake Avastin, from Quality Specialty Products (QSP), a foreign supplier that may also be known as Montana Health Care Solutions.
FDA Seeking Information from Metal Hip Replacement Patients
FDA is looking for information from metal-on-metal hip replacement patients.
The U.S. Food and Drug Administration (FDA) announced it is seeking information from patients regarding their metal-on-metal (MoM) hip systems. If you have had an MoM hip implant, contact our law firm, and our DePuy litigation team will compile your information for the FDA. Attorney David Szerlag is lead attorney for our metal hip recall lawsuits.
FDA will discuss the issues surrounding MoM hip systems at a two-day expert advisory panel meeting on June 27-28, 2012.
There are two categories of MoM hip systems:
- Metal-on-metal total hip replacement systems consisting of a metal ball (femoral head), a metal femoral stem in the thighbone, and a metal cup in the hip bone (acetabular component).
- Metal-on-metal hip resurfacing systems consisting of a trimmed femoral head capped with a metal covering and a metal cup in the hip bone (acetabular component).
Hip replacement surgery is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint in patients where there is evidence of sufficient sound bone to seat and support the components. It is the MoM hip replacement systems that have been the subject of a recall (DePuy recall) numerous lawsuits.
In May 2011, FDA issued an order for manufacturers of MoM hip systems to conduct post-market surveillance studies to collect more safety data on these devices, including data related to metal ion concentrations in the bloodstream. Read about cobalt poisoning and chromium poisoning associated with DePuy ASR hip implants.
The FDA is currently considering whether to make MoM hip systems subject to more rigorous testing and premarket review requirements.
A recent study noting an increased failure rate related to those systems that utilize large-diameter femoral heads has added to the FDA’s existing concerns over the safety of MoM hip systems.
The FDA panel will discuss:
- Failure rates and modes
- Metal ion testing
- Imaging methods
- Local and systemic complications
- Patient risk factors;and
- Considerations for follow-up after surgery.
Pradaxa Lawsuit
Call 888-377-8900 for a free consultation regarding a Pradaxa lawsuit.
Attorney Brendan Flaherty is lead attorney for our Pradaxa lawsuit cases. An investigation of Pradaxa (dabigatran etexilate) has found that this medication can cause irreversible bleeding. In some cases, people who took Pradaxa for a brief period of time were at increased risk for life-threatening bleeding.
Are you someone who suffered from severe bleeding after taking Pradaxa? If so, Brendan Flaherty and his team of attorneys can help you win your case. Contact Brendan for a free consultation regarding your legal rights.
Pradaxa Lawsuit Investigation
Your lawsuit will allege that the Pradaxa you ingested was defective, that the product label and associated documents did not adequately warn you or your doctor of the risk of irreversible bleeding, and that you should be fully compensated you for your injuries. If you are a family member of someone who died from severe bleeding after taking Pradaxa, your lawsuit will allege that it was a wrongful death.
Your Pradaxa lawsuit investigation will require legal procedures to obtain documents from the manufacturer of Pradaxa and related companies: Boehringer Ingleheim Pharmaceuticals, Inc. and Boehringer Ingelheim Pharma Gmb H & Co. KG, Boehringer Ingelheim International Gmb H, and Bidachem Sp. A. (collectively referred to hereafter as Boehringer Ingelheim). In addition, executives of these companies and others will need to be interviewed in the presence of a court reporter. These interviews are called depositions. A list of written questions is also sent to each company. These written questions are called interrogatories.
Some of the questions that need to be answered include the following:
- When did the company know of specific cases of injury and death associated with Pradaxa use?
- Why didn’t the company pull the product off of the market when they knew of the high risk of injury and death?
- Did the company provide the FDA with all relevant results from all clinical trials before the FDA approved the drug for sale in the United States?
- How did the company promote the product and did they fully explain, or explain at all, the risk of irreversible bleeding to doctors?
Attorney Brendan Flaherty and his team can help you get the answers you want and the money you deserve. Contact Brendan for a free Pradaxa case review.
Our attorneys work with local counsel throughout the Unites States to represent clients in product liability injury and death lawsuits. States in which one or more of our attorneys are licensed to practice include: Iowa, Massachusetts, Minnesota, Rhode Island.
Raw Milk Campylobacter Outbreak in Kansas Linked to Mystery Dairy Farm
A Campylobacter outbreak in Kansas linked to raw milk sickened 18 people in January of this year.
In January of this year, 18 people in Kansas drank raw milk contaminated with Campylobacter bacteria and contracted campylobacteriosis, an infection that can cause serious illness, including meningitis and Guillain-Barré Syndrome (GBS). This outbreak was not mentioned by Kansas agriculture or health officials until yesterday, when the Kansas Department of Agriculture issued a press release regarding the dangers of raw milk. Even then, it is a stretch to call this going public with the outbreak because no information was provided other than that 18 people were sickened and the dairy was in south central Kansas.
When we contacted the Department of Agriculture, we could not get any additional information from them. We believe consumers should be told the name of the dairy. In addition, there should have been a recall of any product suspected as the source of the outbreak if there was any chance that the recall would prevent illness.
Contact our Campylobacter lawyers about a lawsuit against the dairy.
